Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of MXN 3.97 trillion. The enterprise value is 4.47 trillion.

Market Cap	3.97T
Enterprise Value	4.47T

Important Dates

The last earnings date was Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	Mar 17, 2025

Share Statistics

Current Share Class	2.51B
Shares Outstanding	n/a
Shares Change (YoY)	-0.30%
Shares Change (QoQ)	-0.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.51B

Valuation Ratios

The trailing PE ratio is 11.13 and the forward PE ratio is 9.00.

PE Ratio	11.13
Forward PE	9.00
PS Ratio	3.04
PB Ratio	4.01
P/TBV Ratio	17.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.81, with an EV/FCF ratio of 12.84.

EV / Earnings	12.55
EV / Sales	3.56
EV / EBITDA	7.81
EV / EBIT	9.33
EV / FCF	12.84

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.72.

Current Ratio	1.41
Quick Ratio	0.83
Debt / Equity	0.72
Debt / EBITDA	1.20
Debt / FCF	2.04
Interest Coverage	19.06

Financial Efficiency

Return on equity (ROE) is 39.29% and return on invested capital (ROIC) is 19.33%.

Return on Equity (ROE)	39.29%
Return on Assets (ROA)	13.81%
Return on Invested Capital (ROIC)	19.33%
Return on Capital Employed (ROCE)	27.14%
Revenue Per Employee	17.66M
Profits Per Employee	4.82M
Employee Count	75,000
Asset Turnover	0.58
Inventory Turnover	2.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.77% in the last 52 weeks. The beta is 0.44, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-32.77%
50-Day Moving Average	1,731.24
200-Day Moving Average	2,000.13
Relative Strength Index (RSI)	44.59
Average Volume (20 Days)	3,580

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.16

Income Statement

In the last 12 months, Merck & Co. had revenue of MXN 1.31 trillion and earned 356.33 billion in profits. Earnings per share was 140.59.

Revenue	1.31T
Gross Profit	1.01T
Operating Income	498.93B
Pretax Income	412.23B
Net Income	356.33B
EBITDA	588.54B
EBIT	498.93B
Earnings Per Share (EPS)	140.59

Full Income Statement

Balance Sheet

The company has 188.61 billion in cash and 712.17 billion in debt, giving a net cash position of -523.56 billion.

Cash & Cash Equivalents	188.61B
Total Debt	712.17B
Net Cash	-523.56B
Net Cash Per Share	n/a
Equity (Book Value)	989.24B
Book Value Per Share	392.64
Working Capital	211.11B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 426.72 billion and capital expenditures -78.46 billion, giving a free cash flow of 348.26 billion.

Operating Cash Flow	426.72B
Capital Expenditures	-78.46B
Free Cash Flow	348.26B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.07%, with operating and profit margins of 38.19% and 27.27%.

Gross Margin	77.07%
Operating Margin	38.19%
Pretax Margin	31.55%
Profit Margin	27.27%
EBITDA Margin	45.05%
EBIT Margin	38.19%
FCF Margin	26.66%

Dividends & Yields

This stock pays an annual dividend of 61.45, which amounts to a dividend yield of 4.15%.

Dividend Per Share	61.45
Dividend Yield	4.15%
Dividend Growth (YoY)	19.61%
Years of Dividend Growth	1
Payout Ratio	45.54%
Buyback Yield	0.30%
Shareholder Yield	4.45%
Earnings Yield	8.98%
FCF Yield	8.78%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.7.

Altman Z-Score	4.7
Piotroski F-Score	n/a